MT-8554 middle dose

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Painful Diabetic Peripheral NeuropathyVasomotor Symptoms

Phase 1

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

CompletedNCT02803268

Tanabe Pharma CorporationVasomotor Symptoms

Start: 2016-06-30End: 2017-01-31Updated: 2025-12-22

Phase 2

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

CompletedNCT03172598

Tanabe Pharma CorporationPainful Diabetic Peripheral Neuropathy

Start: 2017-07-25End: 2018-08-08Updated: 2025-12-22